Effects of prostaglandin F2alpha administration prior to coronary ligation.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003327:Coronary Disease / Q000503:physiopathology*; D003402:Creatine Kinase / Q000097:blood; D000242:Cyclic AMP / Q000378:metabolism; D004285:Dogs; D005260:Female; D005966:Glucuronidase / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000503:physiopathology; D008297:Male; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects
D011461:Prostaglandins F, Synthetic; D000242:Cyclic AMP; D003402:Creatine Kinase; D005966:Glucuronidase